China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Dynamic Prediction Using UltraEarly Hematologic Response and Individualized Therapy in Newly Diagnosed Systemic AL Amyloidosis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135557
Registration Time: 2026/10/30
Type: Observational study
Primary Sponsor: Peking University People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=350116
Published by HT Digital Content Services with permission from Health Daily Digest....